Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4540592
Max Phase: Preclinical
Molecular Formula: C139H231N55O43
Molecular Weight: 3360.72
Molecule Type: Unknown
Associated Items:
ID: ALA4540592
Max Phase: Preclinical
Molecular Formula: C139H231N55O43
Molecular Weight: 3360.72
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C139H231N55O43/c1-10-65(4)102(127(233)193-103(70(9)201)128(234)185-89(56-98(206)207)118(224)170-66(5)104(210)169-68(7)106(212)191-101(64(2)3)130(236)237)192-116(222)85(29-19-51-167-139(157)158)177-109(215)78(22-12-44-160-132(143)144)173-105(211)67(6)171-117(223)86(53-71-31-37-74(202)38-32-71)181-113(219)82(26-16-48-164-136(151)152)176-111(217)80(24-14-46-162-134(147)148)174-110(216)79(23-13-45-161-133(145)146)175-112(218)81(25-15-47-163-135(149)150)178-121(227)90(57-99(208)209)183-119(225)88(55-73-35-41-76(204)42-36-73)184-125(231)96-30-20-52-194(96)129(235)95(63-199)190-115(221)84(28-18-50-166-138(155)156)180-122(228)92(60-196)188-120(226)87(54-72-33-39-75(203)40-34-72)182-108(214)77(21-11-43-159-131(141)142)172-97(205)58-168-107(213)91(59-195)186-124(230)93(61-197)187-114(220)83(27-17-49-165-137(153)154)179-123(229)94(62-198)189-126(232)100(140)69(8)200/h31-42,64-70,77-96,100-103,195-204H,10-30,43-63,140H2,1-9H3,(H,168,213)(H,169,210)(H,170,224)(H,171,223)(H,172,205)(H,173,211)(H,174,216)(H,175,218)(H,176,217)(H,177,215)(H,178,227)(H,179,229)(H,180,228)(H,181,219)(H,182,214)(H,183,225)(H,184,231)(H,185,234)(H,186,230)(H,187,220)(H,188,226)(H,189,232)(H,190,221)(H,191,212)(H,192,222)(H,193,233)(H,206,207)(H,208,209)(H,236,237)(H4,141,142,159)(H4,143,144,160)(H4,145,146,161)(H4,147,148,162)(H4,149,150,163)(H4,151,152,164)(H4,153,154,165)(H4,155,156,166)(H4,157,158,167)/t65-,66-,67-,68-,69+,70+,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,100-,101-,102-,103-/m0/s1
Standard InChI Key: IIBXFUOKWUWBBF-JHKJEGEHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3360.72 | Molecular Weight (Monoisotopic): 3358.7580 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Xu P, Kaas Q, Wu Y, Zhu X, Li X, Harvey PJ, Zhangsun D, Craik DJ, Luo S.. (2020) Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA., 63 (4): [PMID:31986036] [10.1021/acs.jmedchem.9b01409] |
Source(1):